Stay updated on Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial

Sign up to get notified when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The new screenshot shows a redesigned layout and header; study details, eligibility criteria, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T21:11:26.000Z thumbnail image
  3. Check
    32 days ago
    Change Detected
    Summary
    The page has been updated to include a government-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T08:59:52.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.
    Difference
    0.1%
    Check dated 2025-09-29T07:31:21.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Minor patch update: version bumped from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed. No changes to core content, pricing, stock, or other critical data.
    Difference
    0.3%
    Check dated 2025-09-14T23:20:50.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.3%
    Check dated 2025-09-07T20:04:08.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically highlighting Duchenne muscular dystrophy and the drug eteplirsen, while removing previous location terms and related topics.
    Difference
    3%
    Check dated 2025-08-31T12:41:12.000Z thumbnail image

Stay in the know with updates to Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.